|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
19 February 2015 |
|
Main ID: |
NCT01452217 |
|
Date of registration:
|
10/10/2011 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Non-invasive MRI to Quantify the Effect of Secretin on Pancreatic Blood Flow and Perfusion in Healthy Volunteers
|
|
Scientific title:
|
The Use of Non-invasive MRI to Quantify the Effect of Secretin on Pancreatic Blood Flow and Perfusion in Healthy Volunteers |
|
Date of first enrolment:
|
September 2010 |
|
Target sample size:
|
12 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01452217 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
|
|
Phase:
|
Phase 1
|
|
|
Countries of recruitment
|
|
United Kingdom
| | | | | | | |
|
Contacts
|
|
Name:
|
John Simpson, PhD FRCS |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
University of Nottingham |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Male
- Healthy
- Able to give informed consent
Exclusion Criteria:
- Current illness
- Contraindications to magnetic resonance imaging
Age minimum:
18 Years
Age maximum:
75 Years
Gender:
Male
|
|
Health Condition(s) or Problem(s) studied
|
|
Chronic Pancreatitis
|
|
Intervention(s)
|
|
Drug: Secretin
|
|
Primary Outcome(s)
|
|
Pancreatic perfusion
[Time Frame: 0, 5, 10, 20, 30 and 40 min]
|
|
Secondary Outcome(s)
|
|
Splenic artery blood flow
[Time Frame: 0, 5, 10, 20, 30 and 40 min]
|
|
Hepatic artery blood flow
[Time Frame: 0, 5, 10, 20, 30 and 40 min]
|
|
Gastroduodenal artery blood flow
[Time Frame: 0, 5, 10, 20, 30 and 40 min]
|
|
Superior mesenteric artery blood flow
[Time Frame: 0, 5, 10, 20, 30 and 40 min]
|
|
Secondary ID(s)
|
|
D/07/2010
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|